Kyverna Therapeutics (KYTX) Prepaid Assets (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Prepaid Assets of $5.3 million for Q1 2026, up 42.7% on a QoQ basis from $3.7 million in Q4 2025, and up 5.56% year-over-year from $5.0 million in Q1 2025.
Kyverna Therapeutics (KYTX) Prepaid Assets (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Prepaid Assets history runs 4 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- Quarterly Prepaid Assets rose 5.56% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 5.56% YoY) and the FY2025 annual result came in at $3.7 million, down 19.95% from the prior year.
- Prepaid Assets was $5.3 million for Q1 2026 at Kyverna Therapeutics, up from $3.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.7 million in Q1 2024 and bottomed at $2.6 million in Q2 2024.
- A 4-year average of $4.0 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 48.09% — and 2025, when it retreated 19.95%.
- Kyverna Therapeutics' Prepaid Assets stood at $3.1 million in 2023, then surged by 48.09% to $4.6 million in 2024, then slipped by 19.95% to $3.7 million in 2025, then soared by 42.7% to $5.3 million in 2026.
- Business Quant data shows KYTX's Prepaid Assets at $5.3 million in Q1 2026, $3.7 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 3.70 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 5.69 Mn |
| Dec 31, 2023 | 3.12 Mn |